Research Article
Comparison of Treatment Approaches and Subsequent Outcomes within a Pulmonary Embolism Response Team Registry
Table 3
Secondary outcome 2 (major bleeding) by predictors and outcomes of interest
.
| | No bleeding (N = 1702) | Major bleeding (N = 130) | Overall (N = 1832) | Difference t-test or chi-square, value |
| | PE severity at presentation, N (%) | | High risk | 102 (6.0%) | 37 (28.5%) | 139 (7.6%) | <0.001 | | Intermediate-high risk | 661 (38.8%) | 46 (35.4%) | 707 (38.6%) | | | Intermediate-low risk | 931 (54.7%) | 46 (35.4%) | 977 (53.3%) | | | Low risk | 8 (0.5%) | 1 (0.8%) | 9 (0.5%) | |
| | Bleeding risk assessment, N (%) | | High | 220 (12.9%) | 28 (21.5%) | 248 (13.5%) | 0.028 | | Moderate | 857 (50.4%) | 58 (44.6%) | 915 (49.9%) | | | Low | 625 (36.7%) | 44 (33.8%) | 669 (36.5%) | |
| | PE severity/bleeding risk assessment profile, N (%) | | High-risk PE/high bleeding risk | 24.0 (1.4%) | 10.0 (7.7%) | 34 (1.9%) | <0.001 | | High-risk PE/moderate bleeding risk | 52 (3.1%) | 10 (7.7%) | 62 (3.4%) | | | High-risk PE/low bleed risk | 26 (1.5%) | 17 (13.1%) | 43 (2.3%) | | | Intermediate-high PE/high bleeding risk | 99 (5.8%) | 14 (10.8%) | 113 (6.2%) | | | Intermediate-high PE/moderate bleeding risk | 334 (19.6%) | 21 (16.2%) | 355 (19.4%) | | | Intermediate-high PE/low bleeding risk | 228 (13.4%) | 11 (8.5%) | 239 (13.0%) | | | Intermediate-low PE/high bleeding risk | 97 (5.7%) | 4 (3.1%) | 101 (5.5%) | | | Intermediate-low PE/moderate bleeding risk | 468 (27.5%) | 26 (20.0%) | 494 (27.0%) | | | Intermediate-low PE/low bleeding risk | 374 (22.0%) | 17 (13.1%) | 391 (21.3%) | |
| | Outcomes | | Death | 73 (4.3%) | 21 (16.2%) | 94 (5.1%) | <0.001 | | Clinical deterioration | 160 (9.4%) | 58 (44.6%) | 218 (11.9%) | <0.001 |
|
|
The percentages within each cell were calculated by using the N in the column header for that cell. |
